Associated Genetic Biomarkers
Associated Diseases
Associated Pathways

Overview

Gene Location [1]
11q22.3
Pathway
DNA damage/repair
Variant Type
Loss
Gene
ATM

ATM Loss is present in 0.21% of AACR GENIE cases, with chronic lymphocytic leukemia/small lymphocytic lymphoma, mantle cell lymphoma, prostate adenocarcinoma, breast invasive ductal carcinoma, and invasive breast carcinoma having the greatest prevalence [4].

Top Disease Cases with ATM Loss

Biomarker-Directed Therapies

Significance of ATM Loss in Diseases

Prostate Carcinoma +

Malignant Solid Tumor +

Breast Carcinoma +

Prostate Adenocarcinoma +

Ovarian Carcinoma +

Non-Small Cell Lung Carcinoma +

Primary Peritoneal Carcinoma +

Adenocarcinoma Of The Gastroesophageal Junction +

Fallopian Tube Carcinoma +

Urothelial Carcinoma +

Pancreatic Adenocarcinoma +

Pancreatic Carcinoma +

Colorectal Carcinoma +

Gastric Adenocarcinoma +

Non-Hodgkin Lymphoma +

Cervical Carcinoma +

Small Cell Lung Carcinoma +

Endometrial Carcinoma +

Soft Tissue Sarcoma +

Clear Cell Renal Cell Carcinoma +

Gastric Carcinoma +

Head And Neck Carcinoma +

Melanoma +

Head And Neck Squamous Cell Carcinoma +

Lymphoma +

Esophageal Adenocarcinoma +

Esophageal Carcinoma +

High Grade Ovarian Serous Adenocarcinoma +

Gastrointestinal Stromal Tumor +

Bladder Urothelial Carcinoma +

Bladder Carcinoma +

Cholangiocarcinoma +

Multiple Myeloma +

Osteosarcoma +

Squamous Cell Lung Carcinoma +

Mantle Cell Lymphoma +

Pancreatic Ductal Adenocarcinoma +

Neuroblastoma +

B-Cell Non-Hodgkin Lymphoma +

Anal Carcinoma +

Mature T-Cell And NK-Cell Non-Hodgkin Lymphoma +

Malignant Small Intestinal Neoplasm +

Malignant Uterine Neoplasm +

Glioblastoma +

Malignant Esophagogastric Neoplasm +

Malignant Ovarian Epithelial Tumor +

Sarcoma +

Malignant Intestinal Neoplasm +

Colorectal Adenocarcinoma +

Lung Carcinoma +

Acute Lymphoblastic Leukemia +

Acute Myeloid Leukemia +

Ampulla Of Vater Carcinoma +

Anaplastic Astrocytoma +

Bile Duct Adenocarcinoma +

Bile Duct Carcinoma +

Biliary Tract Carcinoma +

Bronchogenic Carcinoma +

Chronic Lymphocytic Leukemia +

Chronic Myeloid Leukemia +

Diffuse Large B-Cell Lymphoma +

Esophageal Squamous Cell Carcinoma +

Ewing Sarcoma +

Gallbladder Carcinoma +

Histiocytic And Dendritic Cell Neoplasm +

Leiomyosarcoma +

Low Grade Ovarian Serous Adenocarcinoma +

Malignant Gastric Neoplasm +

Malignant Mesothelioma +

Mesothelioma +

Myelodysplastic Syndromes +

Ovarian Clear Cell Adenocarcinoma +

Penile Carcinoma +

Prolymphocytic Leukemia +

Rhabdomyosarcoma +

Uveal Melanoma +

Vaginal Carcinoma +

Vulvar Carcinoma +

References

1. Hart R and Prlic A. Universal Transcript Archive Repository. Version uta_20180821. San Francisco CA: Github;2015. https://github.com/biocommons/uta

2. The UniProt Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Research. 2019;47:D506-D515.

3. Liu X, Wu C, Li C, and Boerwinkle E. dbNSFP v3.0: A one-stop database of functional predictions and annotations for human nonsynonymous and splice site SNVs. Human Mutation. 2015;37:235-241.

Liu X, Jian X, and Boerwinkle E. dbNSFP: A lightweight database of human nonsynonymous SNPs and their functional predictions. Human Mutation. 2011;32:894-899.

4. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.

5. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.